Skip to content

GEOVAX LABS, INC.: 10-Q filed 2022-08-03

What GEOVAX LABS, INC. reported in its quarterly report filed 2022-08-03 (fiscal Q2 2022): 32 published measures, 88 facts as tagged in accession 0001437749-22-018639.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-03
Fiscal period
fiscal Q2 2022
Accession
0001437749-22-018639 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GEOVAX LABS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3033,240,525USD
At 2021-12-3111,797,064USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-305,367,868USD
At 2021-12-317,435,360USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-3027,872,657USD
At 2022-03-3111,353,652USD
At 2021-12-314,361,704USD
At 2021-06-3019,458,338USD
At 2021-03-3120,651,340USD
At 2020-12-319,568,852USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-3030,902,454USD
At 2021-12-3111,423,870USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-2,241,699USD91
2022-01-01 to 2022-06-30-4,669,214USD181
2022-01-01 to 2022-03-31-2,427,515USD90
2021-04-01 to 2021-06-30-1,314,033USD91
2021-01-01 to 2021-06-30-2,876,811USD181
2021-01-01 to 2021-03-31-1,562,778USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-8,166,818USD181
2021-01-01 to 2021-06-30-2,879,566USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-06-3082,383USD181
2021-01-01 to 2021-06-3019,929USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-3027,727,785USD181
2021-01-01 to 2021-06-3012,554,212USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-82,383USD181
2021-01-01 to 2021-06-30-19,929USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-69,045,112USD
At 2021-12-31-64,375,898USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3012,721,696shares91
2022-01-01 to 2022-06-309,931,088shares181
2021-04-01 to 2021-06-306,322,799shares91
2021-01-01 to 2021-06-305,830,165shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.18USD/shares91
2022-01-01 to 2022-06-30-0.47USD/shares181
2021-04-01 to 2021-06-30-0.21USD/shares91
2021-01-01 to 2021-06-30-0.49USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-30214,783USD
At 2021-12-31156,938USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-06-30412,329USD181
2021-01-01 to 2021-06-30163,553USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-2,242,488USD91
2022-01-01 to 2022-06-30-4,670,530USD181
2021-04-01 to 2021-06-30-1,486,626USD91
2021-01-01 to 2021-06-30-3,050,702USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-3032,038,234USD
At 2021-12-3111,629,116USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-04-01 to 2022-06-300USD91
2022-01-01 to 2022-06-300USD181
2021-04-01 to 2021-06-30531USD91
2021-01-01 to 2021-06-301,286USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-303,367,868USD
At 2021-12-315,435,360USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-06-30237,315USD
At 2021-12-312,057,534USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-302,242,488USD91
2022-01-01 to 2022-06-304,752,056USD181
2021-04-01 to 2021-06-301,566,334USD91
2021-01-01 to 2021-06-303,240,827USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,307,177USD91
2022-01-01 to 2022-06-302,637,721USD181
2021-04-01 to 2021-06-30832,835USD91
2021-01-01 to 2021-06-301,435,618USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3016,238,739shares
At 2021-12-316,381,541shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-06-30789,542USD
At 2021-12-31707,159USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-06-30574,759USD
At 2021-12-31550,221USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-06-30987,508USD
At 2021-12-3111,010USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-06-302,000,000USD
At 2021-12-312,000,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-303,130,553USD
At 2021-12-313,377,826USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-06-301,135,780USD
At 2021-12-31156,240USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30935,311USD91
2022-01-01 to 2022-06-302,114,335USD181
2021-04-01 to 2021-06-30733,499USD91
2021-01-01 to 2021-06-301,805,209USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-06-3024,538USD181
2021-01-01 to 2021-06-3017,871USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-04-01 to 2022-06-30789USD91
2022-01-01 to 2022-06-301,316USD181
2021-04-01 to 2021-06-30172,593USD91
2021-01-01 to 2021-06-30173,891USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-06-3027,727,194USD181
2021-01-01 to 2021-06-309,408,920USD181

Inspect the source

Entity
GEOVAX LABS, INC. / CIK 0000832489
Captured
2026-09-19T15:08:35.324Z
SEC response SHA-256
59a901b3497fda8a2be64a7de8bb7d8359e460cc8dc7a28f1eaf58764d360937

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000832489.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))